Jun 7, 2026
Andrew Left has never been shy about saying a stock stinks. As the head of Citron Research, the 55-year-old investor became one of the most televised examples of an “activist short seller,” with analyses eviscerating companies like Valeant Pharmaceuticals and Beyond Meat.
But a recent federal trial may force Left to keep his lips sealed.
Advertisement
After a years-long federal investigation, the U.S. Attorney’s Office in the Central District of California ruled Left guilty on multiple counts of securities fraud. According to First Assistant United States Attorney Bill Essayli, “Left used his TV appearances to disguise his intentions, manipulate the stock market and pad his pockets.” Between 2018 and 2023, the court alleged Left made $21 million in these fraudulent stock recommendations.
In most cases, prosecutors argued Left would generate artificial hype with publications from Citron Research or media appearances, all the while taking positions beforehand to capture short-term movements.
One example the court brought up was from 2018, when Left posted on X with news that Citron had just bought Nvidia shares, claiming “We see $165 before we see $120.” Following his post, Nvidia shares rose to $154 before falling to $144. But instead of holding Nvidia shares till it reached $165, Left cashed in on $960,000 with options bought just before the X post.
Left could face up to 25 years in federal prison for his securities fraud scheme. However, social media posts suggest Left will appeal this decision. On Citron Research’s X account, Left argued that “not once” during his trial “did anyone say I lied.” He went on to say he “disagree[s] with the jury and this does not stop here.”
The ‘silencing’ of short sellers
A big question surrounding Left’s conviction is whether this is about just one bad trader, or activist short selling as a practice. Even though some of the examples in Left’s case involved long positions, his prominence as a short seller has made some trading firms fearful.
“It’s tough to know how much of the verdict is due to the general dislike of short sellers versus these Left-specific factors … and the costs to short sellers of making the wrong guess are huge, and that’s where the chilling comes in,” said Peter Molk, a law professor at the University of Florida.
But it appears as though Left’s case simply cemented a fear that many activist short sellers have already sensed. Even though it’s unclear whether this case is solely about Left’s misconduct, many prominent short sellers have erred on the side of caution.
For instance, Bloomberg reported in 2023 that prominent bear Jim Chanos shut down his firm, Chanos & Co., after 38 years.
Advertisement
More recently, Hindenburg Research announced its disbandment in a 2025 blog post. In that message, founder Nathan Anderson gave a sense of the stresses at a modern-day short-focused hedge fund, saying, “I often wake up from my dreams because I’ve thought of a new investigative thread to pull on in my sleep, or an edit that clarifies a point I didn’t realize I was troubled by during the day. Or from the general pressure of it all.”
According to Dr. Frank Zhang of the Yale School of Management, the Left trial has already made activist short sellers a dying breed. As The New York Times reported, Zhang said this case “will scare” short sellers “into silence.”
Must Read
- You can now build wealth like a landlord for as little as $100 — and no, you don't have to chase down rent or take 3 A.M tenant calls
- Goldman Sachs used to hoard prime real estate deals for the ultrarich. Two ex-analysts just opened the door for $250
- Robert Kiyosaki begs investors not to miss this ‘explosion’ — says this 1 asset will surge 400% in a year
Join 250,000+ readers and get Moneywise’s best stories and exclusive interviews first — clear insights curated and delivered weekly. Subscribe now.
Is the short-selling strategy under threat?
It may seem like short selling itself was on trial with Left’s conviction, but keep in mind this was more about market influence than a specific trading strategy.
Scott Nations, president of Nations Indexes, told Reuters he doesn’t believe the Left trial will have any effect on “short selling in general.” Rather, Nations says this case is more troubling for activist-style investors.
As Nations put it, “Once a jury verdict like this lands, it raises the legal and reputational stakes for anyone whose strategy relies on broadcasting displeasure as part of the thesis.”
At the most basic level, Left’s conviction was a classic case of market manipulation. Just because he happened to favor short selling doesn’t mean investors can’t have vocal opinions about a company and even bet against it. The rub is that there’s obviously a point at which sharing info turns into misleading the public.
Exactly where that dividing line is between legit criticisms and illicit influence is still being worked out, which explains why more prominent short-focused firms are closing operations. Without a clearer framework for activist investors, it’s likely that more shorts will stay in the shadows.
You May Also Like
- Dave Ramsey warns nearly 50% of Americans are making 1 big Social Security mistake — here’s what it is and the simple steps to fix it ASAP
- Thanks to Jeff Bezos, you can now become a landlord for as little as $100 — and no, you don't have to deal with tenants or fix freezers. Here's how
- Millionaires under 43 are reshaping investing — just 25% of their portfolios are in stocks. Here’s where their money is going
- Robert Kiyosaki issues grim warning for baby boomers. Many could be ‘wiped out’ and homeless ‘all over’ the country. How to protect yourself now
Eric Esposito is a freelance contributor on MoneyWise who loves making financial topics accessible and understandable to readers. In addition to MoneyWise, Eric’s work can be found in publications such as WallStreetZen and CoinDesk.
